Today: 21 May 2026
Target stock ticks up in premarket as activist stake report keeps pressure on turnaround
29 December 2025
2 mins read

Target stock ticks up in premarket as activist stake report keeps pressure on turnaround

NEW YORK, December 29, 2025, 05:20 ET — Premarket

  • Target shares were up 0.3% in premarket trading at $99.87.
  • Investors stayed focused on a report that activist fund Toms Capital Investment Management built a stake in the retailer.
  • Traders are watching for details on the activist’s plans as Target heads into a CEO transition.

Target shares edged higher in premarket trading on Monday, extending attention on the retailer after news of an activist investor stake drove a late-week rally.

The move matters because it adds pressure on Target’s turnaround effort as the company prepares for a leadership change and tries to revive demand after a prolonged sales slump.

Target was up 0.3% at $99.87 as of 5:30 a.m. ET, according to market data on Public.com. The stock last closed at $99.55.

The Financial Times reported on Friday that New York-based Toms Capital Investment Management (TCIM) had made a “significant” investment in Target, without disclosing the size of the stake or what it wants the company to do. Financial Times+1

Target told Reuters it maintains regular dialogue with the investment community and that its top priority is getting back to growth. TCIM did not respond to Reuters requests for comment.

Target’s stock has lost more than 28% of its value this year, Reuters reported, after the company posted three straight quarters of falling comparable sales — sales at established stores and online that investors track as a gauge of underlying demand.

The activist news lands ahead of Chief Operating Officer Michael Fiddelke taking over as CEO in February, while current CEO Brian Cornell is set to become executive chairman — a governance setup that has drawn scrutiny from some shareholders.

Nonprofit shareholder group the Accountability Board said the TCIM position shows investors are “hungry for change,” after it filed a proposal urging Target to appoint an independent chairman. Reuters

“Financial games and monetization do not take Target in the right direction,” Neil Saunders, managing director at retail research firm GlobalData, wrote in an email. Reuters

Target has tried to reassure investors with plans to spend an additional $1 billion in 2026 on new stores, remodels and improvements to its digital business, Reuters reported. The company has also cut 1,800 corporate roles as part of a restructuring.

The company’s real estate footprint remains in focus for investors weighing what an activist might target. Target owns about 75% of its real estate, including the land, UBS analyst Michael Lasser estimated, Reuters said.

TCIM is a lesser-known name in retail activism, but Reuters said it took a stake in Tylenol maker Kenvue ahead of its sale to Kimberly-Clark last month and has pushed for changes at Kellanova and U.S. Steel.

Target has faced activists before, including a 2009 proxy battle with Pershing Square’s Bill Ackman over a proposed real-estate spinoff that shareholders rejected, Reuters reported.

Investors are now watching for any SEC filing that could spell out TCIM’s ownership and intentions, alongside any signals from Target’s board about strategy, governance and how it plans to compete on price and essentials against larger peers such as Walmart and Amazon.

Target’s investor relations site currently lists no future events scheduled, leaving the next concrete catalyst tied to company disclosures and the run-up to the CEO handover.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
D-Wave stock slides into year-end as quantum peers retreat in thin trade
Previous Story

D-Wave stock slides into year-end as quantum peers retreat in thin trade

Tesla drops in premarket as supplier slashes battery deal from $2.9 bln to $7,386
Next Story

Tesla drops in premarket as supplier slashes battery deal from $2.9 bln to $7,386

Go toTop